Health Condition 1: K582- Mixed irritable bowel syndrome
Conditions
Interventions
Intervention1: 1. Jatiphaladi Churna
: Dose: 2gm twice daily
Dosage form: Churna (powder)
Route of Administration : Oral
Time of Administration : Twice a day after food
Anupana : Water
Duration o
Sponsors
CCRASNew Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex aged 18-65 years 2. Known cases of Grahani (diagnostic criteria as per classical Ayurvedic Parameters) with following symptoms 3. Patients willing to give written informed consent and able to participate for 3 months.
Exclusion criteria
Exclusion criteria: 1. Patients with history of Inflammatory Bowel Disease (IBD), Kochâ??s Abdomen, Gluten Intolerance. 2. Patients with history of chronic amoebiasis. 3. Known cases of Diabetes Mellitus. 4. Patients with poorly controlled Hypertension ( >160/100 mmHg) 5. Patients who have history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months 6. Symptomatic patients with clinical evidence of Heart failure 7. Known cases of malignancy 8. Patients with concurrent serious hepatic disorders (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease (COPD). 9. Women who are planning for conception / pregnant or lactating. 10. H/o hypersensitivity to any of the trial drugs or their ingredients 11. Patients who have completed participation in any other clinical trial during the past three months 12. Any other condition which the Investigator thinks may jeopardize the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the clinical efficacy of Jatiphaladya Churna & Chitrakadi Gutika by the assessment of Changes in Ayurvedic Parameters of Grahani Timepoint: Base line , At the end of 14th day, 28th day, 42nd day, 56th day, and 70th day, 84th day and 98th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the clinical efficacy of Jatiphaladya Churna & Chitrakadi Gutika by the assessment of Changes in IBS-QOL scoreTimepoint: Base line , At the end of 14th day, 28th day, 42nd day, 56th day, and 70th day, 84th day and 98th day. | — |
Countries
India
Contacts
Public ContactDr Purnendu Panda
Centra Ayurveda Research Institute For Hepatobiliary Disorders, Bharatpur, Bhubaneswar
Outcome results
None listed